There's a lot of pressure to even the playing field so that Americans are paying no more or less than the rest of the world, ... It places downward pressure on pricing, and I think the pressure will be so great that the prices of drugs will be lower vs. higher, and that will be a negative in the industry overall. And I don't think that's fully priced in the stocks. That's why we're not fully buying into that sector. Romeo Dator